DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...

A new wearable patch can detect early signs of the deadliest form of skin cancer. The wireless device allows screening of ...

Enspectra Health today announced the publication of pivotal clinical trial results in JAMA Dermatology, demonstrating that its handheld cross-modal imaging system enables physicians to accurately ...

A new wearable patch can detect early signs of the deadliest form of skin cancer. The wireless device allows screening of ...

This is likely the first case report on primary cutaneous follicle center lymphoma associated with bone marrow mastocytosis.

Recent vitiligo research has challenged long-held assumptions about skin cancer risk in patients with depigmented lesions. A ...

WINSTON-SALEM, N.C. — Researchers at Wake Forest University's School of Medicine have developed a battery-free, chip-less ...

A new wearable patch can detect early signs of the deadliest form of skin cancer. The wireless device allows screening of ...

It could empower patients and primary care providers to monitor suspicious skin lesions and seek help sooner." The patch is ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Basal cell carcinoma, or BCC, is the most common form of skin cancer globally, but it is also highly curable. This guide is designed to provide newly diagnosed patients with the necessary information ...